AADI — Aadi Bioscience Balance Sheet
0.000.00%
Last trade - 00:00
- $42.97m
- -$65.88m
- $24.35m
- 18
- 53
- 25
- 23
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 38.5 | 42.6 | 149 | 173 | 109 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 1.86 | 5.49 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 39.6 | 44.7 | 151 | 180 | 125 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.326 | 0.186 | 0.614 | 2.03 | 5.97 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 39.9 | 44.9 | 158 | 184 | 132 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.33 | 1.87 | 15.3 | 18.8 | 26.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.4 | 1.87 | 21.5 | 25.9 | 27.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 36.5 | 43.1 | 136 | 158 | 105 |
Total Liabilities & Shareholders' Equity | 39.9 | 44.9 | 158 | 184 | 132 |
Total Common Shares Outstanding |